Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 93 for

Edit search filters
  1. A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

    Rochester, MN

  2. An Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan to Treat Patients with Pulmonary Arterial Hypertension

    Scottsdale/Phoenix, AZ

  3. A Study to Evaluate the Safety and Effectiveness of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)

    Jacksonville, FL

  4. An Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil

    Rochester, MN

  5. A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

    Jacksonville, FL

  6. A Study Evaluating the Long-Term Effectiveness and Safety of Ralinepag in Subjects with PAH Via an Open-Label Extension

    Jacksonville, FL

  7. A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension

    Jacksonville, FL

  8. A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension

    Rochester, MN

  9. Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

    Rochester, MN

  10. A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical Treatment CTEPH

    Rochester, MN

.

Mayo Clinic Footer